DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,776 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $333,800 | +0.1% | 1,336 | 0.0% | 0.10% | -4.7% |
Q1 2024 | $333,626 | +4.1% | 1,336 | -3.6% | 0.11% | -2.8% |
Q4 2023 | $320,637 | -2.8% | 1,386 | +4.2% | 0.11% | -10.7% |
Q3 2023 | $329,973 | +5.4% | 1,330 | +1.9% | 0.12% | +8.9% |
Q2 2023 | $313,200 | -1.0% | 1,305 | +4.0% | 0.11% | -6.7% |
Q1 2023 | $316,310 | +13.0% | 1,255 | +19.0% | 0.12% | +6.2% |
Q4 2022 | $280,018 | -20.0% | 1,055 | -22.1% | 0.11% | -22.6% |
Q3 2022 | $350,000 | +0.3% | 1,355 | -1.5% | 0.15% | +10.6% |
Q2 2022 | $349,000 | -12.8% | 1,375 | +0.7% | 0.13% | +7.3% |
Q1 2022 | $400,000 | +25.8% | 1,365 | +41.5% | 0.12% | +28.1% |
Q4 2021 | $318,000 | +8.2% | 965 | 0.0% | 0.10% | +2.1% |
Q3 2021 | $294,000 | +13.5% | 965 | 0.0% | 0.09% | +14.6% |
Q2 2021 | $259,000 | +19.4% | 965 | 0.0% | 0.08% | +6.5% |
Q1 2021 | $217,000 | +1.4% | 965 | 0.0% | 0.08% | -10.5% |
Q4 2020 | $214,000 | +2.9% | 965 | 0.0% | 0.09% | -7.5% |
Q3 2020 | $208,000 | -47.6% | 965 | -77.4% | 0.09% | -41.5% |
Q4 2017 | $397,000 | +8.5% | 4,275 | +0.1% | 0.16% | +7.4% |
Q3 2017 | $366,000 | +4.0% | 4,270 | +2.4% | 0.15% | -2.0% |
Q2 2017 | $352,000 | +1.1% | 4,170 | +2.5% | 0.15% | -4.4% |
Q1 2017 | $348,000 | +11.2% | 4,070 | +1.1% | 0.16% | +9.7% |
Q4 2016 | $313,000 | -0.6% | 4,025 | +0.1% | 0.14% | -5.3% |
Q3 2016 | $315,000 | – | 4,020 | – | 0.15% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
Third Point | 3,570,000 | $494,124,000 | 7.88% |